Analyst Consensus ?
ConsensusHold46 ratings
Bullish1328.3%
Neutral2656.5%
Bearish715.2%
FN2 Earnings Intelligence
The Mosaic Company (MOS) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 30, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Oct 27, 2026 |
| CIBC | Neutral | Neutral | Maintain | Oct 23, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 16, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Oct 13, 2026 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Oct 5, 2026 |
| Freedom Broker | Sell | Buy | Downgrade | Aug 13, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 30, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | May 21, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 14, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | May 12, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Apr 20, 2026 |
| B of A Securities | Neutral | Buy | Downgrade | Mar 20, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Nov 12, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 15, 2025 |
| Piper Sandler | Neutral | Neutral | Maintain | Jan 27, 2025 |
| Stifel | Hold | Hold | Maintain | Oct 4, 2023 |
| Credit Suisse | Underperform | Underperform | Maintain | Aug 2, 2023 |
| HSBC | Hold | Reduce | Upgrade | Jul 26, 2023 |
| Berenberg | Hold | Hold | Maintain | May 16, 2023 |
| Citigroup | Neutral | Neutral | Maintain | Feb 27, 2023 |
| Exane BNP Paribas | Underperform | Neutral | Downgrade | Jan 13, 2023 |
| VTB Capital | Sell | Hold | Downgrade | Nov 25, 2020 |
| Cleveland Research | Buy | Neutral | Upgrade | Sep 23, 2020 |
| Susquehanna | Positive | Positive | Maintain | Apr 9, 2020 |
| CFRA | Hold | Strong Buy | Downgrade | Apr 3, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Nov 7, 2019 |
| Consumer Edge Research | Equal Weight | Equal Weight | Maintain | Sep 23, 2019 |
| Bank of America | Buy | Neutral | Upgrade | Jun 17, 2019 |
| Standpoint Research | Hold | Buy | Downgrade | Aug 10, 2018 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Mar 5, 2018 |
| Stephens & Co. | Overweight | Overweight | Maintain | Feb 2, 2018 |
| Vertical Research | Hold | Sell | Upgrade | Aug 17, 2017 |
| Atlantic Equities | Neutral | Underweight | Upgrade | May 9, 2017 |
| CLSA | Outperform | Buy | Maintain | Feb 8, 2017 |
| Societe Generale | Sell | Buy | Downgrade | Feb 16, 2016 |
| Bernstein | Outperform | Market Perform | Upgrade | Oct 13, 2015 |
| BGC Financial | Sell | Hold | Downgrade | Aug 13, 2014 |
| Macquarie | Neutral | Outperform | Downgrade | May 22, 2014 |
| RS Platou Markets | Buy | Buy | Maintain | Jan 9, 2014 |
| Deutsche Bank | Hold | Hold | Maintain | Apr 1, 2013 |
| Dahlman Rose | Hold | Buy | Downgrade | Feb 22, 2013 |
| PiperJaffray | Hold | Neutral | Maintain | Dec 3, 2012 |
| Canaccord Genuity | Hold | Buy | Downgrade | Nov 14, 2012 |
| Topeka Capital | Hold | Hold | Maintain | Oct 3, 2012 |
| Topeka | Hold | Hold | Maintain | Oct 3, 2012 |
| Ameriprise Financial | Buy | Buy | Maintain | Aug 15, 2012 |
Upside is calculated against the persisted current price $18.23. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $19 | $18.32 | +4.2% | Oct 27, 2026 |
| CIBC | Hamir Patel | $22 | $17.54 | +20.7% | Oct 23, 2026 |
| Barclays | Analyst unavailable | $22 | $18.95 | +20.7% | Oct 16, 2026 |
| Mizuho Securities | Analyst unavailable | $22 | $18.85 | +20.7% | Oct 13, 2026 |
| RBC Capital | Andrew Wong | $25 | $21.07 | +37.1% | Oct 5, 2026 |
| Mizuho Securities | Edlain Rodriguez | $25 | $22.71 | +37.1% | Aug 5, 2026 |
| Morgan Stanley | Analyst unavailable | $26 | $22.44 | +42.6% | Jun 30, 2026 |
| Redburn Partners | Analyst unavailable | $30 | $21.73 | +64.6% | Jun 26, 2026 |
| BMO Capital | Analyst unavailable | $31 | $21.67 | +70.0% | May 21, 2026 |
| Scotiabank | Ben Isaacson | $30 | $21.58 | +64.6% | May 19, 2026 |
| Barclays | Analyst unavailable | $26 | $21.76 | +42.6% | May 18, 2026 |
| Wells Fargo | Analyst unavailable | $22 | $22.78 | +20.7% | May 14, 2026 |
| CIBC | Analyst unavailable | $25 | $21.64 | +37.1% | May 12, 2026 |
| UBS | Lucas Beaumont | $23 | $21.71 | +26.2% | May 12, 2026 |
| Mizuho Securities | Analyst unavailable | $24 | $21.79 | +31.7% | May 12, 2026 |
| CIBC | Analyst unavailable | $27 | $23.56 | +48.1% | Apr 30, 2026 |
| Wells Fargo | Michael Sison | $25 | $24.11 | +37.1% | Apr 21, 2026 |
| Scotiabank | Analyst unavailable | $33 | $23.96 | +81.0% | Apr 20, 2026 |
| Wells Fargo | Michael Sison | $27 | $28.16 | +48.1% | Jan 23, 2026 |
| RBC Capital | Andrew Wong | $29 | $26.35 | +59.1% | Jan 20, 2026 |
| Oppenheimer | Kristen Owen | $35 | $26.54 | +92.0% | Jan 16, 2026 |
| Morgan Stanley | Analyst unavailable | $35 | $26.21 | +92.0% | Jan 14, 2026 |
| UBS | Analyst unavailable | $33 | $25.73 | +81.0% | Jan 12, 2026 |
| RBC Capital | Analyst unavailable | $27 | $23.5 | +48.1% | Dec 10, 2025 |
| Goldman Sachs | Analyst unavailable | $33 | $25.71 | +81.0% | Nov 12, 2025 |
| Scotiabank | Analyst unavailable | $36 | $25.86 | +97.5% | Nov 10, 2025 |
| CIBC | Analyst unavailable | $32 | $25.56 | +75.5% | Nov 6, 2025 |
| Oppenheimer | Analyst unavailable | $40 | $28.98 | +119.4% | Oct 22, 2025 |
| Mizuho Securities | Edlain Rodriguez | $34 | $29.29 | +86.5% | Oct 20, 2025 |
| Wells Fargo | Analyst unavailable | $32 | $29.79 | +75.5% | Oct 16, 2025 |
| UBS | Analyst unavailable | $40 | $30.35 | +119.4% | Oct 13, 2025 |
| RBC Capital | Analyst unavailable | $30 | $30.77 | +64.6% | Oct 10, 2025 |
| Scotiabank | Analyst unavailable | $34 | $33.44 | +86.5% | Oct 10, 2025 |
| Barclays | Analyst unavailable | $44 | $34.79 | +141.4% | Oct 9, 2025 |
| UBS | Analyst unavailable | $44 | $34.83 | +141.4% | Oct 6, 2025 |
| Scotiabank | Ben Isaacson | $42 | $33.68 | +130.4% | May 14, 2025 |
| Barclays | Benjamin Theurer | $40 | $32.95 | +119.4% | May 14, 2025 |
| Piper Sandler | Charles Neivert | $30 | $27.48 | +64.6% | Mar 27, 2025 |
| Scotiabank | Analyst unavailable | $31 | $23.33 | +70.0% | Mar 3, 2025 |
| Mizuho Securities | Analyst unavailable | $28 | $23.33 | +53.6% | Mar 3, 2025 |
| Wells Fargo | Analyst unavailable | $26 | $23.33 | +42.6% | Mar 3, 2025 |
| Piper Sandler | Charles Neivert | $26 | $25.84 | +42.6% | Nov 18, 2024 |
| BMO Capital | Joel Jackson | $44 | $27.05 | +141.4% | Nov 13, 2024 |
| Scotiabank | Ben Isaacson | $38 | $25.68 | +108.4% | Sep 17, 2024 |
| Barclays | Benjamin Theurer | $32 | $27.7 | +75.5% | Aug 16, 2024 |
| CIBC | Jacob Bout | $35 | $30.5 | +92.0% | Jul 18, 2024 |
| UBS | Joshua Spector | $30 | $27.03 | +64.6% | Jul 9, 2024 |
| Piper Sandler | Charles Neivert | $28 | $28.76 | +53.6% | Jun 11, 2024 |
| Stifel Nicolaus | Vincent Anderson | $32 | $29.54 | +75.5% | May 13, 2024 |
| Piper Sandler | Charles Neivert | $29 | $29.72 | +59.1% | May 7, 2024 |
| RBC Capital | Andrew Wong | $32 | $28.68 | +75.5% | May 6, 2024 |
| CIBC | Jacob Bout | $36 | $29.09 | +97.5% | May 3, 2024 |
| Mizuho Securities | Edlain Rodriguez | $33 | $28.41 | +81.0% | May 3, 2024 |
| Stifel Nicolaus | Vincent Anderson | $35 | $32.89 | +92.0% | Apr 8, 2024 |
| UBS | Analyst unavailable | $54 | $44.64 | +196.2% | Jan 11, 2023 |
| Morgan Stanley | Analyst unavailable | $55 | $44.41 | +201.7% | Jan 11, 2023 |
| Credit Suisse | John Roberts | $60 | $43.82 | +229.1% | Jul 14, 2022 |
| Mizuho Securities | Analyst unavailable | $89 | $62.49 | +388.2% | Apr 29, 2022 |
| RBC Capital | Analyst unavailable | $85 | $75.77 | +366.3% | Apr 21, 2022 |
| Piper Sandler | Charles Neivert | $80 | $61.14 | +338.8% | Mar 7, 2022 |
| Scotiabank | Ben Isaacson | $49 | $45.25 | +168.8% | Feb 24, 2022 |
| Berenberg Bank | Sebastian Bray | $50 | $45.25 | +174.3% | Feb 24, 2022 |
| Mizuho Securities | Chris Parkinson | $59 | $45.1 | +223.6% | Feb 23, 2022 |
| UBS | John Roberts CFA | $53 | $45.1 | +190.7% | Feb 23, 2022 |
| Barclays | Duffy Fischer | $43 | $39.31 | +135.9% | Nov 3, 2021 |
| Bank of America Securities | Steve Byrne | $49 | $29.39 | +168.8% | Jul 16, 2021 |
| Stephens | Mark Connelly | $45 | $34.61 | +146.8% | May 5, 2021 |
| VTB Capital | Elena Sakhnova | $32 | $34.88 | +75.5% | Apr 30, 2021 |
Track every rating change on MOS the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.